Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714439 · ClinicalTrials.gov registry record · Early Phase 1
Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley
A Early Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 157
- Enrollment target
NCT02714439: Clinical Trial Early Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT02714439 is a Early Phase 1 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 157 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (196% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02714439, a Early Phase 1 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" (HRME) for the diagnosis of cervical pre-cancerous lesions and cervical cancer. The investigators want to compare patients' clinical findings using the current equipment used in clinic with the clinical findings using new equipment we are testing on this research project. If the new equipment is proven to give comparable findings with current equipment being used, doctors might be able to offer a diagnosis and treat cervical lesions in one visit. It might not be necessary to wait for cervical biopsies to come back before women would receive the indicated treatment. Study subjects are being asked to participate because they have been diagnosed with an abnormal Papanicolaou (Pap) PAP smear, positive human papillomavirus (HPV) test or history of cervical dysplasia and need to have a colposcopic examination to determine the reason for abnormal results and receive treatment.
Primary Outcome
Successful outcome defined as concordance between the diagnosis using HRME imaging and the most severe histologic diagnosis.
Interventions
- DRUG Proflavine
- PROCEDURE High-Resolution Microendoscopy (HRME)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2024-02-09 |
| Phase | Early Phase 1 |
Why NCT02714439 stopped before completion
NCT02714439 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (196% higher).
The record links to 0 conditions, and to 2 interventions - of which Proflavine is the first listed.
NCT02714439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02714439 about?
NCT02714439 is a clinical study titled "Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley". The purpose of this study is to evaluate a different type of medical equipment called "High-Resolution Microendoscope" (HRME) for the diagnosis of cervical pre-cancerous lesions and cervical cancer. The investigators want to compare patients' clinical findings using the current equipment used in cli...
What is the current status of trial NCT02714439?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 157 participants. The study started on 2016-10-25. Estimated completion is 2024-02-09.
What interventions are being tested in trial NCT02714439?
The interventions under investigation include: Proflavine (DRUG), High-Resolution Microendoscopy (HRME) (PROCEDURE).
Who is sponsoring clinical trial NCT02714439?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02714439's enrollment target sits among peer trials
157 95th of 2000 higher than 1,906 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI